Virological diagnosis of Ebolavirus infection

Pathology

Volumn 47, Issue 5, 2015, Pages 410-413

  Smith, D W ^a,b   Rawlinson, W D ^c,d   Kok, J ^e,f,g   Dwyer, D E ^e,f,g   Catton, M ^h  

^a PATHWEST LABORATORY MEDICINE   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c New South Wales Health Pathology   (Australia)

^d UNIVERSITY OF NEW SOUTH WALES   (Australia)

^e WESTMEAD HOSPITAL   (Australia)

^f University of Sydney   (Australia)

^g UNIVERSITY OF SYDNEY   (Australia)

^h VICTORIAN INFECTIOUS DISEASES REFERENCE LABORATORY   (Australia)

Author keywords

Diagnosis; Ebola; Filovirus; PCR; quality

Indexed keywords

AUSTRALIA; DISEASE OUTBREAKS; EBOLAVIRUS; HEALTH CARE QUALITY; HEMORRHAGIC FEVER, EBOLA; HUMAN; ISOLATION AND PURIFICATION; LABORATORY; PUBLIC HEALTH;

AUSTRALIA; DISEASE OUTBREAKS; EBOLAVIRUS; HEMORRHAGIC FEVER, EBOLA; HUMANS; LABORATORIES; PUBLIC HEALTH; QUALITY ASSURANCE, HEALTH CARE;

EID: 84988938838     PISSN: 00313025     EISSN: 14653931     Source Type: Journal    
DOI: 10.1097/PAT.0000000000000292     Document Type: Article

References (23)

1. Public Health Laboratory Network. Laboratory procedures and precautions for samples collected from patients with suspected viral haemorrhagic fevers. Canberra: Australian Government Department of Health, 2014. Cited 24 Apr 2015. http://www.health.gov.au/internet/main/publishing.nsf/Content/cda-pubs-other-vhf.htm .
2. A. Sanchez T.W. Geisbert H. Feldmann Filoviridae: Marburg and Ebola viruses D.M. Knipe D.E. Griffin R.A. Lamb Fields Virology 5th ed 2007 Lippincott Williams & Wilkins Philadelphia 1409 1448
3. J.S. Kuhn G. Kristian K.G. Andersen Nomenclature- and database-compatible names for the two Ebola virus variants that emerged in Guinea and the Democratic Republic of the Congo in 2014 Viruses 6 2014 4760 4799
4. G. Gire A. Goba K. Andersen Genomic surveillance elucidates Ebola virus origin and transmission during the 2014 outbreak Science 345 2014 1369 1372
5. World Health Organization. Laboratory Guidance for the Diagnosis of Ebola Virus Disease: Interim Recommendations. 19 September 2014; cited 24 Apr 2015. http://www.who.int/csr/resources/publications/ebola/labora-tory-guidance/en/ .
6. C.O. Onyango M.L. Opoka T.G. Ksiazek Laboratory diagnosis of Ebola hemorrhagic fever during an outbreak in Yambio, Sudan, 2004 J Infect Dis 196 Suppl 2 2007 S193 S198
7. J.S. Towner P.E. Rollin D.G. Bausch Rapid diagnosis of Ebola hemorrhagic fever by reverse transcription-PCR in an outbreak setting and assessment of patient viral load as a predictor of outcome J Virol 78 2004 4330 4341
8. D.S. Chertow C. Kleine J.K. Edwards Ebola virus disease in West Africa -clinical manifestations and management N Engl J Med 371 2014 2054 2057
9. P. Formenty E.M. Leroy A. Epelboin Detection of Ebola virus in oral fluid specimens during outbreaks of Ebola virus hemorrhagic fever in the Republic of Congo Clin Infect Dis 42 2006 1521 1526
10. J.B. Varkey J.G. Shantha I. Crozier Persistence of Ebola virus in ocular fluid during convalescence N Engl J Med 372 2015 2423 2427
11. L.L. Rodriguez R.oo A. De Y. Guimard Persistence and genetic stability of Ebola virus during the outbreak in Kikwit, Democratic Republic of the Congo, 1995 J Infect Dis 179 Suppl 1 1999 S170 S176
12. M. Moreau C. Spencer J.G. Gozalbes Lactating mothers infected with Ebola virus: EBOV RT-PCR of blood only may be insufficient Euro Surveill 20 2015 21017
13. S.E. Bellan J.R. Pulliam J. Dushoff Ebola control: effect of asymptomatic infection and acquired immunity Lancet 384 2014 1499 1500
14. C. Reusken M. Niedrig S. Pas Identification of essential outstanding questions for an adequate European laboratory response to Ebolavirus Zaire West Africa 2014 J Clin Virol 62 2015 124 134
15. US Food and Drug Administration. Emergency Use Authorisation. Cited 27 Apr 2015. http://www.fda.gov/EmergencyPreparedness/Counterterrorism/MedicalCountermeasures/MCMLegalRegulatoryandPolicyFramework/ucm182568.htm .
16. J.A. Blow D.J. Dohm D.L. Negley Virus inactivation by nucleic acid extraction reagents J Virol Methods 119 2004 195 198
17. J.S. Towner T.K. Sealy T.G. Ksiazek High-throughput molecular detection of hemorrhagic fever virus threats with applications for outbreak settings J Infect Dis 196 Suppl 2 2007 S205 s212
18. TM polymerase chain reaction assays for detection and absolute quantification of filoviruses, arenaviruses, and new world hantaviruses Am J Trop Med Hyg 82 2010 954 960
19. Communicable Disease Network of Australia. Ebola virus disease (EVD): CDNA National Guidelines for Public Health Units. Cited 21 Apr 2015. http://www.health.gov.au/internet/main/publishing.nsf/Content/ohp-ebola-Information-for-Health-Professionals .
20. Centers for Disease Control. Guidance for collection, transport and submission of samples for Ebola virus testing. Cited 27 Apr 2015. http://www.cdc.gov/vhf/ebola/healthcare-us/laboratories/specimens.html .
21. T.G. Ksiazek P.E. Rollin A.J. Williams Clinical virology of Ebola hemorrhagic fever (EHF): virus, virus antigen, and IgG and IgM antibody findings among EHF patients in Kikwit, Democratic Republic of the Congo, 1995 J Infect Dis 179 Suppl 1 1999 S177 S187
22. TM Antigen Rapid Test Kit (EA 0011-011-00) 2015. Cited 27 Apr 2014. http://www.who.int/medicines/ebola-treatment/1st_antigen_RT_Ebola/en/ .
23. T.G. Ksiazek C.P. West P.E. Rollin ELISA for the detection of antibodies to Ebola viruses J Infect Dis 179 Suppl 1 1999 S192 S198